drugset / Trial / NCT06184581

Lithium Versus Lamotrigine in Bipolar Disorder, Type II

NCT06184581

Phase 4 Recruiting 200 enrolled University Hospital Bispebjerg and Frederiksberg
RandomizedParallel-groupSingle-blindTreatment

Summary

The investigators want in a 6-month randomized controlled trial (RCT) to compare effects of lithium versus lamotrigine on mood stabilization and other critical patient outcomes in patients with BDII.

Timeline

Start
2024-05-08
Primary completion
2027-12-01
Completion
2027-12-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lamotrigine Small molecule
Subject Lithium Unknown

Indications